MBX Butterfly Strategy
MBX (MBX Biosciences, Inc. Common Stock), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
MBX Biosciences, Inc. is a biopharmaceutical company in its clinical development phase, dedicated to pioneering precise peptide-based therapies for endocrine and metabolic conditions. Its most advanced drug candidate, MBX 2109, is a parathyroid hormone peptide prodrug currently in Phase 2 clinical trials. This medication is being evaluated as a long-duration hormone replacement treatment for individuals suffering from chronic hypoparathyroidism. The company is also progressing with MBX 1416, a prolonged-action glucagon-like peptide-1 (GLP-1) receptor antagonist, which is undergoing Phase 1 clinical assessment. The aim of this therapy is to address post-bariatric hypoglycemia, a persistent complication often seen after weight-loss surgery. Furthermore, MBX Biosciences is developing MBX 4291, a key candidate for obesity treatment.
MBX (MBX Biosciences, Inc. Common Stock) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $2.78B, a beta of 0.10 versus the broader market, a 52-week range of 23.07-72.64, average daily share volume of 551K, a public-listing history dating back to 2024, approximately 63 full-time employees. These structural characteristics shape how MBX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.10 indicates MBX has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a butterfly on MBX?
A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration.
MBX snapshot
As of November 13, 2026, spot at $56.38, ATM IV 136.80%, IV rank 59.29%, expected move 39.22%. The butterfly on MBX below is built from the November 13, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this butterfly structure on MBX specifically: MBX IV at 136.80% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 39.22% (roughly $22.11 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated MBX expiries trade a higher absolute premium for lower per-day decay. Position sizing on MBX should anchor to the underlying notional of $56.38 per share and to the trader's directional view on MBX stock.
MBX butterfly setup
The MBX butterfly below is built from the November 13, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With MBX at $56.38 on that close, the first option leg uses a $55.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed MBX chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 MBX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $55.00 | $9.00 |
| Sell 2 | Call | $55.00 | $9.00 |
| Buy 1 | Call | $60.00 | $7.85 |
MBX butterfly risk and reward
- Net Premium / Debit
- +$115.00
- Max Profit (per contract)
- $115.00
- Max Loss (per contract)
- -$385.00
- Breakeven(s)
- $56.15
- Risk / Reward Ratio
- 0.299
Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit.
MBX butterfly payoff curve
Modeled P&L at expiration across a range of underlying prices for the butterfly on MBX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | +$115.00 |
| $12.47 | -77.9% | +$115.00 |
| $24.94 | -55.8% | +$115.00 |
| $37.40 | -33.7% | +$115.00 |
| $49.87 | -11.5% | +$115.00 |
| $62.33 | +10.6% | -$385.00 |
| $74.80 | +32.7% | -$385.00 |
| $87.26 | +54.8% | -$385.00 |
| $99.73 | +76.9% | -$385.00 |
| $112.19 | +99.0% | -$385.00 |
When traders use butterfly on MBX
Butterflies on MBX are pinning bets - traders use them when they expect MBX to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
MBX thesis for this butterfly
The market-implied 1-standard-deviation range for MBX extends from approximately $34.27 on the downside to $78.49 on the upside. A MBX long call butterfly is a pinning play: it pays maximum at the middle strike if MBX settles there at expiration, with the wing legs capping both the cost and the maximum loss to the net debit. Current MBX IV rank near 59.29% is mid-range against its 1-year distribution, so the IV signal is neutral; the butterfly thesis on MBX should anchor more to the directional view and the expected-move geometry. As a Healthcare name, MBX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to MBX-specific events.
MBX butterfly positions are structurally neutral / pin (limited-risk, limited-reward); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. MBX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move MBX alongside the broader basket even when MBX-specific fundamentals are unchanged. Always rebuild the position from current MBX chain quotes before placing a trade.
Frequently asked questions
- What is a butterfly on MBX?
- A butterfly on MBX is the butterfly strategy applied to MBX (stock). The strategy is structurally neutral / pin (limited-risk, limited-reward): A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration. With MBX stock at $56.38 on the November 13, 2026 close, the strikes shown on this page are snapped to the nearest listed MBX chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are MBX butterfly max profit and max loss calculated?
- Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit. For the MBX butterfly priced from the November 13, 2026 end-of-day chain at a 30-day expiry (ATM IV 136.80%), the computed maximum profit is $115.00 per contract and the computed maximum loss is -$385.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a MBX butterfly?
- The breakeven for the MBX butterfly priced on this page is roughly $56.15 at expiration, derived from the November 13, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The MBX market-implied 1-standard-deviation expected move in the same options snapshot is approximately 39.22%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a butterfly on MBX?
- Butterflies on MBX are pinning bets - traders use them when they expect MBX to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
- How does current MBX implied volatility affect this butterfly?
- MBX ATM IV is at 136.80% with IV rank near 59.29%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.